跳至主要内容
临床试验/NCT01558388
NCT01558388Unknown4 期

Randomised Control Trial of Probiotics Versus Placebo as Adjuvant to Oral Clindamycin Treatment for Bacterial Vaginosis During Pregnancy

Università degli Studi di Brescia1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
Vaginal lactobacillus recolonization

研究概览

简要总结

Bacterial vaginosis is a common vaginal condition involving a reduction in the amount of Lactobacilli, the normal bacteria colonizing the vagina, and an overgrowth of pathogenic bacteria. The presence of bacterial vaginosis in pregnancy is associated with an increased risk of preterm delivery. After a course of antibiotic treatment, recurrence of bacterial vaginosis has been reported in 10-70% of cases. This study aims to verify if administration of vaginal Lactobacilli may reduce the occurrence rate after antibiotic treatment of bacterial vaginosis during pregnancy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • singleton pregnancy
  • gestational age 12-32 weeks
  • diagnosis of bacterial vaginosis
  • treatment of bacterial vaginosis with oral clindamycin 300 mg, twice-daily for 7 days

排除标准

  • multiple pregnancy
  • allergy to clindamycin

研究组 & 干预措施

Vaginal lactobacilli

Experimental

干预措施: Lactobacillus acidophilus (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Vaginal lactobacillus recolonization

时间窗: 3-5 weeks

Recurrence rate of bacterial vaginosis

时间窗: 3-5 weeks

次要结局

  • Preterm delivery <37 weeks(within 43 weeks of gestation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Federico Prefumo

Consultant in Obstetrics and Gynaecology

Università degli Studi di Brescia

研究点 (1)

Loading locations...

相似试验